Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alda Di Chiara"'
Autor:
Alda Di Chiara, Carlo Federico Zambon, Mario Plebani, Marco La Malfa, Paul Aiyetan, Daniela Basso, Rino Bellocco, Girolamo Pavanello, Daniel W. Chan, Andrea Padoan, Hui Zhang
MALDI-TOF profiling of low molecular weight peptides (peptidome) usage is limited due to the lack of reproducibility from the confounding inferences of sample preparation, data acquisition, and processing. We applied MALDI-TOF analysis to profile uri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1363372bc42c0ebd3c46d59e8daec198
http://hdl.handle.net/10281/103506
http://hdl.handle.net/10281/103506
Autor:
Mario Plebani, Giovanni de Manzoni, Luigi Cristadoro, Andrea Padoan, Daniela Basso, Eliana Greco, Sergio Pedrazzoli, Girolamo Pavanello, Alberto Marchet, Alda Di Chiara, Filippo Navaglia, Paola Fogar, Cosimo Sperti, Donato Nitti, Roberta Seraglia, Stefania Moz, Carlo-Federico Zambon
Publikováno v:
Pancreas (Online) 42 (2013): 622–632. doi:10.1097/MPA.0b013e318273096c
info:cnr-pdr/source/autori:Padoan A.; Seraglia R.; Basso D.; Fogar P.; Sperti C.; Moz S.; Greco E.; Marchet A.; De Manzoni G.; Zambon C.-F.; Navaglia F.; Cristadoro L.; Di Chiara A.; Nitti D.; Pedrazzoli S.; Pavanello G.; Plebani M./titolo:Usefulness of MALDI-TOF%2FMS identification of low-MW fragments in sera for the differential diagnosis of pancreatic cancer/doi:10.1097%2FMPA.0b013e318273096c/rivista:Pancreas (Online)/anno:2013/pagina_da:622/pagina_a:632/intervallo_pagine:622–632/volume:42
info:cnr-pdr/source/autori:Padoan A.; Seraglia R.; Basso D.; Fogar P.; Sperti C.; Moz S.; Greco E.; Marchet A.; De Manzoni G.; Zambon C.-F.; Navaglia F.; Cristadoro L.; Di Chiara A.; Nitti D.; Pedrazzoli S.; Pavanello G.; Plebani M./titolo:Usefulness of MALDI-TOF%2FMS identification of low-MW fragments in sera for the differential diagnosis of pancreatic cancer/doi:10.1097%2FMPA.0b013e318273096c/rivista:Pancreas (Online)/anno:2013/pagina_da:622/pagina_a:632/intervallo_pagine:622–632/volume:42
OBJECTIVES: To identify new biomarkers of pancreatic cancer (PaCa), we performed MALDI-TOF/MS analysis of sera from 22 controls, 51 PaCa, 37 chronic pancreatitis, 24 type II diabetes mellitus (DM), 29 gastric cancer (GC), and 24 chronic gastritis (CG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ca7c530929a49c99d3200fc65104069
http://www.cnr.it/prodotto/i/301770
http://www.cnr.it/prodotto/i/301770
Autor:
Padoan, Andrea, Roberta, Seraglia, Paola, Fogar, Sperti, Cosimo, Moz, Stefania, Greco, Eliana, Alberto, Marchet, Zambon, CARLO-FEDERICO, Filippo, Navaglia, Alda di Chiara, Nitti, Donato, Sergio, Pedrazzoli, Girolamo, Pavanello, Pasquali, Claudio, Plebani, Mario, Basso, Daniela
Context New serum biomarkers are needed for pancreatic cancer (PCa) diagnosis especially among patients with diabetes mellitus (DM), a risk factor for and a consequence of PCa. Objective To validate new serum biomarkers identified by MALDI-TOF/MS for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d97b06fb7007af7d8990059c1671b00
http://hdl.handle.net/11577/2526090
http://hdl.handle.net/11577/2526090